Sarah Hersey

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

Grzegorz S. Nowakowski, Annalisa Chiappella, Randy D. Gascoyne et al. · Journal of Clinical Oncology · 2021 · 252 citations · Full text

Biological impact of iberdomide in patients with active systemic lupus erythematosus

Peter E. Lipsky, Ronald van Vollenhoven, Thomas Dörner et al. · Annals of the Rheumatic Diseases · 2022 · 35 citations · Full text

Direct comparison of circulating tumor DNA sequencing assays with targeted large gene panels

Lizhi Yu, Gonzalo Lopez, John Rassa et al. · PLoS ONE · 2022 · 23 citations · Full text

2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral &amp; Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry ( <u>Part 2</u> – Recommendations on Biomarkers/CDx Assays Development &amp; Validation, Cytometry Validation &amp; Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents &amp; Positive Controls Generation)

Sarah Hersey, Steve Keller, Joel Mathews et al. · Bioanalysis · 2022 · 23 citations

Preclinical Therapeutics, Cell Therapy, Engineering +30

Reviews Preclinical Safety and Immune-Modulating Effects of Therapeutic Monoclonal Antibodies to Interleukin-6 and Tumor Necrosis Factor-α in Cynomolgus Macaques

Pauline L. Martin, Joel B. Cornacoff, Uma Prabhakar et al. · Journal of Immunotoxicology · 2005 · 19 citations · Full text